Literature DB >> 26780631

How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach.

Ali Rezaie1,2, Mark Pimentel3, Satish S Rao4.   

Abstract

Small intestinal bacterial overgrowth (SIBO) is characterized by an excessive amount of bacteria in the small intestine and a constellation of symptoms that include bloating, pain, gas, and diarrhea. Although known for many decades, there is a lack of consensus and clarity regarding the natural history and methods for its diagnosis. Several tests have been proposed, including the glucose breath test, lactulose breath test, small intestinal aspiration and culture, and others. However, there is a lack of standardization of these tests and their interpretation. Treatment of SIBO remains empirical; generally, broad spectrum antibiotics are recommended for 2 weeks (amoxicillin, rifaximin, ciprofloxacin, etc.) but evidence for their use is fair. Clearly, there is a strong need to develop a systematic approach for the management of SIBO and to perform multicenter clinical trials for the treatment of SIBO. In this review, we will discuss the current evidence for the diagnosis and treatment of SIBO, which includes (1) elimination/modification of the underlying causes, (2) induction of remission (antibiotics and elemental diet), and (3) maintenance of remission (promotility drugs, dietary modifications, repeat or cyclical antibiotics).

Entities:  

Keywords:  Antibiotics; Elemental diet; Glucose breath test; Lactulose breath test; Promotility drugs; Small intestinal aspiration and culture; Small intestinal bacterial overgrowth (SIBO)

Mesh:

Substances:

Year:  2016        PMID: 26780631     DOI: 10.1007/s11894-015-0482-9

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  57 in total

Review 1.  Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth.

Authors:  S C Shah; L W Day; M Somsouk; J L Sewell
Journal:  Aliment Pharmacol Ther       Date:  2013-09-04       Impact factor: 8.171

2.  Antibiotic treatment of constipation-predominant irritable bowel syndrome.

Authors:  Mark Pimentel; Christopher Chang; Kathleen Shari Chua; James Mirocha; John DiBaise; Satish Rao; Meridythe Amichai
Journal:  Dig Dis Sci       Date:  2014-05-01       Impact factor: 3.199

Review 3.  Irritable bowel syndrome and small intestinal bacterial overgrowth.

Authors:  David Yamini; Mark Pimentel
Journal:  J Clin Gastroenterol       Date:  2010 Nov-Dec       Impact factor: 3.062

4.  Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome.

Authors:  Evangelos Giamarellos-Bourboulis; Jie Tang; Emmannouil Pyleris; Aikaterini Pistiki; Charalambos Barbatzas; Jordan Brown; Clarence C Lee; Timothy T Harkins; Gene Kim; Stacy Weitsman; Gillian M Barlow; Vincent A Funari; Mark Pimentel
Journal:  Scand J Gastroenterol       Date:  2015-04-11       Impact factor: 2.423

Review 5.  The migrating motor complex: control mechanisms and its role in health and disease.

Authors:  Eveline Deloose; Pieter Janssen; Inge Depoortere; Jan Tack
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-03-27       Impact factor: 46.802

6.  The degree of breath methane production in IBS correlates with the severity of constipation.

Authors:  Soumya Chatterjee; Sandy Park; Kimberly Low; Yuthana Kong; Mark Pimentel
Journal:  Am J Gastroenterol       Date:  2007-04       Impact factor: 10.864

Review 7.  Use and abuse of hydrogen breath tests.

Authors:  M Simrén; P-O Stotzer
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

Review 8.  Brain-gut-microbiota axis in Parkinson's disease.

Authors:  Agata Mulak; Bruno Bonaz
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

Review 9.  Methanogens, methane and gastrointestinal motility.

Authors:  Konstantinos Triantafyllou; Christopher Chang; Mark Pimentel
Journal:  J Neurogastroenterol Motil       Date:  2013-12-30       Impact factor: 4.924

10.  Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth.

Authors:  Victor Chedid; Sameer Dhalla; John O Clarke; Bani Chander Roland; Kerry B Dunbar; Joyce Koh; Edmundo Justino; Eric Tomakin; Gerard E Mullin
Journal:  Glob Adv Health Med       Date:  2014-05
View more
  43 in total

1.  Is small intestinal bacterial overgrowth a cause of hyperdynamic circulation in cirrhosis?

Authors:  Roman Maslennikov; Chavdar Pavlov; Vladimir Ivashkin
Journal:  Turk J Gastroenterol       Date:  2019-11       Impact factor: 1.852

2.  Diagnostic Utility of Carbohydrate Breath Tests for SIBO, Fructose, and Lactose Intolerance.

Authors:  Mercedes Amieva-Balmori; Enrique Coss-Adame; Nikilesh S Rao; Brisa M Dávalos-Pantoja; Satish S C Rao
Journal:  Dig Dis Sci       Date:  2019-10-15       Impact factor: 3.199

Review 3.  Beyond pancreatic insufficiency and liver disease in cystic fibrosis.

Authors:  Stephanie Demeyer; Kris De Boeck; Peter Witters; Katrien Cosaert
Journal:  Eur J Pediatr       Date:  2016-04-07       Impact factor: 3.183

Review 4.  Current Knowledge of Necrotizing Enterocolitis in Preterm Infants and the Impact of Different Types of Enteral Nutrition Products.

Authors:  Jocelyn Shulhan; Bryan Dicken; Lisa Hartling; Bodil Mk Larsen
Journal:  Adv Nutr       Date:  2017-01-17       Impact factor: 8.701

5.  Small Intestinal Bacterial Overgrowth and Coronary Artery Disease: What Is in the CArDs?

Authors:  Christopher Adkins; Ali Rezaie
Journal:  Dig Dis Sci       Date:  2018-02       Impact factor: 3.199

Review 6.  Nutritional Recommendations for Adult Bariatric Surgery Patients: Clinical Practice.

Authors:  Shiri Sherf Dagan; Ariela Goldenshluger; Inbal Globus; Chaya Schweiger; Yafit Kessler; Galit Kowen Sandbank; Tair Ben-Porat; Tali Sinai
Journal:  Adv Nutr       Date:  2017-03-15       Impact factor: 8.701

7.  Effect of Bifidobacterium infantis 35624 (Align) on the Lactulose Breath Test for Small Intestinal Bacterial Overgrowth.

Authors:  Krishma Kumar; Mohammed Saadi; Frederick V Ramsey; Ron Schey; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2018-02-03       Impact factor: 3.199

8.  Association Between Small Intestinal Bacterial Overgrowth by Glucose Breath Test and Coronary Artery Disease.

Authors:  Andre Fialho; Andrea Fialho; Gursimran Kochhar; Aldo L Schenone; Prashanti Thota; Arthur J McCullough; Bo Shen
Journal:  Dig Dis Sci       Date:  2017-11-06       Impact factor: 3.199

9.  Testing and Treating Small Intestinal Bacterial Overgrowth Reduces Symptoms in Patients with Inflammatory Bowel Disease.

Authors:  Shirley Cohen-Mekelburg; Zaid Tafesh; Elliot Coburn; Russell Weg; Neena Malik; Colleen Webb; Hoda Hammad; Ellen Scherl; Brian P Bosworth
Journal:  Dig Dis Sci       Date:  2018-05-14       Impact factor: 3.199

10.  Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome.

Authors:  Ashok K Tuteja; Nicholas J Talley; Gregory J Stoddard; G Nicholas Verne
Journal:  Dig Dis Sci       Date:  2018-10-28       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.